Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F4D6C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,522
Award facts
- Contract value 100% obligated
- $32,522.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Zepbound 10 mg/0.5 ml pen injectors valued at $32,522.39, with an ultimate completion date of December 18, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a substantial $999,999,999.00 vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs.
Zepbound, a GLP-1 receptor agonist medication used for weight management, represents one of many pharmaceutical products AmerisourceBergen supplies to federal healthcare systems through its prime vendor relationship with the Defense Logistics Agency. As a major pharmaceutical distributor and critical vendor for military and veteran healthcare procurement, AmerisourceBergen maintains an extensive portfolio of delivery orders covering specialty medications, vaccines, and medical supplies across multiple therapeutic domains. This delivery order supports the Defense Health Agency and other federal healthcare systems requiring access to specialized pharmaceutical commodities through DLA's streamlined procurement mechanisms.
Quick answers
Who was awarded contract SPE2DR26F4D6C?
SPE2DR26F4D6C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26F4D6C worth?
The government has obligated $32,522 on SPE2DR26F4D6C.
Is contract SPE2DR26F4D6C an order under another contract?
Yes. SPE2DR26F4D6C is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4D6C competed?
The extent of competition for SPE2DR26F4D6C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award